Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 91.3K | -153.5K | 7.9K | 88.4K |
Selling general and admin | 1.9M | 1.5M | 797.4K | 796.8K |
Other operating expenses | — | 0 | 36 | 93 |
Operating income | -2.0M | -1.3M | -828.0K | -915.8K |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 321 | 358 | 389 | 461 |
Other income expense | 16.1K | -6.6K | 4.6K | -504 |
Pretax income | -2.0M | -1.3M | -823.8K | -916.8K |
Tax provision | 0 | — | — | 0 |
Net income | -2.0M | -1.3M | -823.8K | -916.8K |
Basic EPS | -0.1 | — | 0.0 | 0.0 |
Diluted EPS | -0.1 | — | 0.0 | 0.0 |
Basic average shares | 30.0M | — | 30.0M | 30.0M |
Diluted average shares | 30.0M | — | 30.0M | 30.0M |
EBITDA | -2.0M | -1.3M | -816.0K | -909.0K |
Net income from continuing op. | -2.0M | -1.3M | — | -916.8K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |